Free Trial

Guardant Health (GH) Earnings Date, Estimates & Call Transcripts

Guardant Health logo
$31.67 +0.54 (+1.73%)
(As of 12/20/2024 05:16 PM ET)

Guardant Health Latest Earnings Summary

Actual EPS
(Nov. 6)
-$0.88 Missed By -$0.33
Consensus EPS
(Nov. 6)
-$0.55

Guardant Health released Q3 2024 earnings on November 6, 2024, reporting an EPS of -$0.88, which missed the consensus estimate of -$0.55 by $0.33. Quarterly revenue rose 33.9% year-over-year to $191.48 million, above analyst estimates of $170.49 million. With a trailing EPS of -$4.24, Guardant Health's earnings are expected to grow next year, from ($3.44) to ($3.11) per share.

Get Guardant Health Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Guardant Health and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

GH Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

GH Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Guardant Health Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20243-$0.97-$0.72-$0.82
Q2 20243-$0.90-$0.68-$0.78
Q3 20243-$0.88-$0.65-$0.79
Q4 20243-$0.90-$0.61-$0.79
FY 202412-$3.65-$2.66-$3.19
Q1 20251-$0.87-$0.87-$0.87
Q2 20251-$0.85-$0.85-$0.85
Q3 20251-$0.86-$0.86-$0.86
Q4 20251-$0.86-$0.86-$0.86
FY 20254($3.44)($3.44)($3.44)

Guardant Health Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
11/6/2024Q3 2024-$0.55-$0.88 -$0.33-$0.88$170.49M$191.48M
8/7/2024Q2 2024-$0.74-$0.84 -$0.10-$0.58$162.59M$177.24M
5/9/2024Q1 2024-$0.94-$0.94--$0.94$150.51M$168.49M
2/22/2024Q4 2023-$0.93-$1.58 -$0.65-$1.58$151.71M$155.05M
11/6/2023Q3 2023-$0.93-$0.73+$0.20-$0.73$137.25M$143.03M
8/3/2023Q2 2023-$1.25-$0.67+$0.58-$0.67$129.44M$137.15M
5/9/2023Q1 2023-$1.26-$1.30 -$0.04-$1.30$117.65M$128.71M
2/23/2023Q4 2022-$1.40-$1.36+$0.04-$1.36$125.43M$126.89M

Guardant Health Earnings - Frequently Asked Questions

Guardant Health (NASDAQ:GH) last announced its quarterly earning data on Wednesday, November 6, 2024. Learn more on GH's earnings history.

Guardant Health issued an update on its FY 2024 earnings guidance on Wednesday, November, 6th. The company issued revenue guidance of $720.0 million-$725.0 million, compared to the consensus revenue estimate of $695.2 million.

In the previous quarter, Guardant Health (NASDAQ:GH) missed the analysts' consensus estimate of ($0.55) by $0.33 with a reported earnings per share (EPS) of ($0.88). Learn more on analysts' earnings estimate vs. GH's actual earnings.

The conference call for Guardant Health's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Guardant Health's latest earnings report can be read online.
Read Transcript

Guardant Health's earnings report can be found in their filing with the SEC.
View SEC filing

Guardant Health (NASDAQ:GH) has a recorded annual revenue of $692.26 million.

Guardant Health (NASDAQ:GH) has a recorded net income of -$479.45 million. GH has generated -$4.24 earnings per share over the last four quarters.

Guardant Health's earnings are expected to grow from ($3.44) per share to ($3.11) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:GH) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners